Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04453722 · ClinicalTrials.gov registry record
Prevention of Opioid-Induced Hypoxemia
A clinical trial of Non-cardiac Surgery, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 49
- Enrollment target
- 1
- Study location
NCT04453722 is a study of Non-cardiac Surgery that has completed, run by The Cleveland Clinic. The registered enrollment target is 49 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04453722, a study of Non-cardiac Surgery, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 49 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate the feasibility of a fully randomized validation trial for the Oxalert EPO.
Conditions Studied
Interventions
- DEVICE Oxalert Monitor Mode
- DEVICE Oxalert Normal mode
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2020-06-26 |
| Est. Completion | 2023-06-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04453722
The ClinicalTrials.gov registry entry for NCT04453722 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Non-cardiac Surgery appearing as the primary indexed condition, and to 2 interventions - of which Oxalert Monitor Mode is the first listed.
NCT04453722 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT04453722 about?
NCT04453722 is a clinical study titled "Prevention of Opioid-Induced Hypoxemia". To evaluate the feasibility of a fully randomized validation trial for the Oxalert EPO.
What is the current status of trial NCT04453722?
This trial is currently completed. The enrollment target is 49 participants. The study started on 2020-06-26. Estimated completion is 2023-06-15.
What conditions does trial NCT04453722 study?
This clinical trial studies the following conditions: Non-cardiac Surgery.
What interventions are being tested in trial NCT04453722?
The interventions under investigation include: Oxalert Monitor Mode (DEVICE), Oxalert Normal mode (DEVICE).
Who is sponsoring clinical trial NCT04453722?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04453722 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.